Navigation Links
NIH scientist to receive Ross Prize in Molecular Medicine
Date:4/23/2014

John J. O'Shea, M.D., scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), has been named the 2014 recipient of the Ross Prize in Molecular Medicine, conferred by the Feinstein Institute's peer-reviewed, open-access journal Molecular Medicine. The award will be given on June 9 at the New York Academy of Sciences in Manhattan, followed by scientific presentations by Dr. O'Shea and other prominent researchers. NIAMS is part of the National Institutes of Health.

The award, which includes a $50,000 prize from Feinstein Institute board members Robin and Jack Ross, is bestowed upon an active investigator who has produced innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine.

"John's scientific achievements in molecular immunology have been transformative. His work exemplifies the bridge between basic research and clinical practice. We are very proud of John and congratulate him on this honor," said NIAMS Director Stephen I. Katz, M.D., Ph.D.

Dr. O'Shea has been a physician and immunologist at NIH for 33 years. He has made fundamental discoveries related to the signaling of cytokines, molecules that are critical for the development and functioning of the immune system. His research also has focused on the molecular cause of primary immunodeficiencies, inherited conditions in which immune function is impaired, and the genetic basis of autoinflammatory disorders, conditions in which the body attacks its own tissues. He was awarded a U.S. patent for his work on Janus family kinase inhibitors as a new class of immunosuppressive drugs. Dr. O'Shea developed a Cooperative Research and Development Agreement with the pharmaceutical company Pfizer, which generated one such compound that is approved for the treatment of rheumatoid arthritis.

Dr. O'Shea graduated Phi Beta Kappa from St. Lawrence University, Canton, N.Y., and he received an M.D. from the University of Cincinnati. After completing his residency in internal medicine at the State University of New York Upstate Medical University, Syracuse, he received subspecialty training in allergy and immunology at NIH. He was appointed chief of the NIAMS Molecular Immunology and Inflammation Branch in 2002, and became scientific director of the NIAMS Intramural Research Program in 2005. Dr. O'Shea has been the recipient of numerous awards and is a Fellow of the American Association for the Advancement of Science.


'/>"/>

Contact: Trish Reynolds
reynoldsp2@mail.nih.gov
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Source:Eurekalert

Related medicine news :

1. Scientists identify cancer specific cell for potential treatment of gastric cancer
2. Scientists pinpoint protein that could improve small cell lung cancer therapies
3. AMP publishes curriculum recommendations for medical laboratory scientists
4. Scientists alter fat metabolism in animals to prevent most common type of heart disease
5. Scientists discover a new way to enhance nerve growth following injury
6. Scientists find key steps linking dietary fats and colon cancer tumor growth
7. Stanford scientists identify source of most cases of invasive bladder cancer
8. Scientists discover brains anti-distraction system
9. Scientists find new way to fight malaria drug resistance
10. Stanford scientists develop playbook for reverse engineering tissue
11. Scientists unlock secrets of protein produced by disease-causing fungus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... 2017 , ... As we celebrate our nation’s independence, many Americans will gather ... perfect time to celebrate National Hot Dog Month. The National Hot Dog and ... July 4th alone and while they enjoy many different kinds of hot dogs, research ...
(Date:6/28/2017)... ... 2017 , ... Continually at the forefront of sweetener innovation, ... received the Non-GMO Project Verified seal. All five flavors of the plant-based, sugar-free ... verification for non-GMO foods and products in North America. , Available in Caramel, ...
(Date:6/28/2017)... ... 28, 2017 , ... Hayes, Inc., a leading provider of ... speaker lineup* for its second annual Client Symposium. Joining the symposium this year ... Fernandez of Privia Health; and Lisa Tourville of Anthem. , “We are ...
(Date:6/28/2017)... ... June 28, 2017 , ... David B. Sosin, a founding partner at the ... the post of 2nd Vice President for the Illinois State Bar Association , in ... ISBA’s 3rd Vice President in 2016 following a state-wide election and served in that capacity ...
(Date:6/28/2017)... Clara, CA (PRWEB) , ... June 28, 2017 , ... ... hosting a free AFM Luncheon for all SEMICONWest attendees and Park customers ... luncheon will feature talks from Dr. Sang-il Park, Chairman & CEO of Park Systems, ...
Breaking Medicine News(10 mins):
(Date:6/12/2017)... 2017 Kineta, Inc., a biotechnology company focused on ... Vice President of R&D and Head of Virology Kristin Bedard ... for the Northwest and Beyond meeting sponsored by Life ... 2017 from 8:30-10:30 AM PDT at the Agora Conference Center ... Dr. Bedard will be joined by other leaders in infectious ...
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... URBANDALE, Iowa , June 6, 2017  Diplomat Specialty Infusion ... a sterile compounding environment to its Iowa ... Urbandale now features an ISO 7 cleanroom—the ... a controlled environment with a low level of pollutants. ... serve more IV nutrition consumers and better serve our ...
Breaking Medicine Technology: